Didier Coquoz
Career history of Didier Coquoz
Former positions of Didier Coquoz
| Companies | Position | Start | End |
|---|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Corporate Officer/Principal | - | 01/12/2014 |
BioLingus (Cayman) Ltd.
 BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Founder | 08/08/2018 | - |
Training of Didier Coquoz
| University of Geneva | Graduate Degree |
Statistics
International
| France | 2 |
| Switzerland | 2 |
| Cayman Islands | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
| Founder | 1 |
Sectoral
| Commercial Services | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
BioLingus (Cayman) Ltd.
BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Didier Coquoz
- Experience
